A Randomized Crossover Study Using Yohimbine and Isoxsuprine Versus Pentoxifylline in the Management of Vasculogenic Impotence

L. Dean Knoll, Ralph C. Benson, David L. Bilhartz, Peter J. Minich, William L. Furlow

The Journal of Urology · 1996 · 13 citations · 17 references

Concepts

Abstract

No AccessJournal of UrologyClinical Urology: Original Article1 Jan 1996A Randomized Crossover Study Using Yohimbine and Isoxsuprine Versus Pentoxifylline in the Management of Vasculogenic Impotence L. Dean Knoll, Ralph C. Benson, David L. Bilhartz, Peter J. Minich, and William L. Furlow L. Dean KnollL. Dean Knoll More articles by this author , Ralph C. BensonRalph C. Benson More articles by this author , David L. BilhartzDavid L. Bilhartz More articles by this author , Peter J. MinichPeter J. Minich More articles by this author , and William L. FurlowWilliam L. Furlow More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)66576-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: We evaluated the efficacy and safety of yohimbine and isoxsuprine or pentoxifylline in the management of vasculogenic erectile dysfunction. Materials and Methods: A total of 20 patients diagnosed with arterial insufficiency and cavernous venous leakage by pharmacological penile duplex scanning underwent nonhormonal oral therapy. A randomized crossover study was performed using 5.4 mg. yohimbine plus 10 mg. isoxsuprine or 400 mg. pentoxifylline 3 times daily. Response to therapy was assessed by a sexual questionnaire and repeat penile duplex ultrasonography. Results: No patient in either phase of the study in either group had a complete response to the oral regimen(s) and there was no improvement in the pre-injection or post-injection cavernous arterial peak systolic flow velocities or resistance indexes. Conclusions: Our study suggests that these oral agents, although well tolerated, were not effective in the management of these patients with mixed vasculogenic erectile dysfunction. References 1 : Oral and transcutaneous pharmacologic agents in the treatment of impotence. Urol. Clin. N. Amer.1988; 15: 87. Google Scholar 2 : Evaluating medical treatment of impotence. Urology1984; 23: 374. Google Scholar 3 : Nonhormonal pharmacological treatment of organic impotence. J. Urol.1982; 128: 45. Link, Google Scholar 4 : Trazadone in diagnosis and therapy of erectile dysfunction: preliminary results. Int. J. Impoten. Res.1992; 4: A100. Google Scholar 5 : Nonoperative management of impotence. J. Urol.1988; 139: 2. Link, Google Scholar 6 : Diagnosis and therapy of erectile dysfunction. In: . Philadelphia: W. B. Saunders Co.1992: 3033. chapt. 84. Google Scholar 7 : Approaches for the development of oral drug therapies for erectile dysfunction. Sem. Urol.1990; 8: 107. Google Scholar 8 : Treatment of impotence with trazadone: a case report. J. Urol.1990; 143: 819. Abstract, Google Scholar 9 : Comparison of the responses to drugs acting on adrenoreceptors and muscarinic receptors in human isolated corpus cavernosum and cavernous artery. J. Auton. Pharmacol.1985; 5: 81. Google Scholar 10 : Norepinephrine involvement in penile detumescence. J. Urol.1990; 143: 1264. Link, Google Scholar 11 : Pharmacological studies of human erectile tissue: characteristics of spontaneous contractions and alterations in alpha-adrenoreceptor responsiveness with age and disease in isolated tissues. Brit. J. Pharmacol.1990; 101: 375. Google Scholar 12 : Neuromorphology and neuropharmacology of the human penis: an in vitro study. J. Clin. Invest.1980; 65: 506. Google Scholar 13 : Andrology. J. Urol.1994; 152: 891. Abstract, Google Scholar 14 : Impotence: a patient's goal-directed approach. Monogr. Urol.1992; 13: 99. Google Scholar 15 : Interpretation and quantification of penile blood flow studies using duplex ultrasonography. J. Urol.1991; 146: 1271. Link, Google Scholar 16 : Evaluation of vasculogenic erectile impotence using penile duplex ultrasonography. J. Urol.1989; 142: 1469. Link, Google Scholar 17 : High resolution Ultrasonography and pulsed wave Doppler for detection of corporovenous incompetence in erectile dysfunction. J. Urol.1990; 143: 1125. Link, Google Scholar 18 : The value of increased end diastolic velocity during penile duplex sonography in relation to pathological venous leakage in erectile dysfunction. J. Urol.1992; 148: 314. Link, Google Scholar 19 : The value of dynamic color duplex scanning in the diagnosis of venogenic impotence. J. Urol.1992; 148: 318. Link, Google Scholar 20 : Relation of intracorporal pressure and end-diastolic velocity during duplex Doppler sonography in the evaluation of venoocclusive dysfunction. Int. J. Impotence Res.1994; 6: 125. Google Scholar 21 : Assessment of penile blood flow by duplex ultrasonography in 44 men with normal erectile potency in different phases of erection. J. Urol.1992; 147: 51. Link, Google Scholar 22 : Improved hemodynamic response after long-term intracavernous injection for impotence. Urology1994; 43: 844. Google Scholar 23 : Local control of human penile helicine arterioles in vitro. J. Urol., part 21989; 141: 544A. abstract 1515. Google Scholar Center for Urological Treatment and Research, Nashville, Tennessee.© 1996 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 155Issue 1January 1996Page: 144-146 Advertisement Copyright & Permissions© 1996 by American Urological Association, Inc.MetricsAuthor Information L. Dean Knoll More articles by this author Ralph C. Benson More articles by this author David L. Bilhartz More articles by this author Peter J. Minich More articles by this author William L. Furlow More articles by this author Expand All Advertisement PDF downloadLoading ...

References

17